Tibbiyah announces half year results

Tibbiyah announces half year results

- Good performance from Premma (medical supplies)

- Supply chain issues amplifying cyclicality of sales for FMS (medical equipment)

- Personnel investments set to support future growth

- IPO guidance unchanged and SAR 60 mn in full year dividend paid in July’22

Riyadh, Saudi Arabia: Arabian International Healthcare Holding Company (“Tibbiyah” or the “Company”, 9530 on the Saudi Exchange’s Nomu - parallel market), a leading integrated healthcare solutions provider in Saudi Arabia, announced its financial results for the six months ended 30 June 2022 (“H1 2022”), reporting a decline in revenues and profitability on the prior comparable period (“H1 2021”). The unfavorable comparison is mostly driven by delayed sales in H1 2022 due to global supply chain disruption, as well as higher profitability Covid-19 related sales in H1 2021 which did not repeat in H1 2022. The above was anticipated, leads to a comparable growth in H1 excluding the impact of the one- offs and do not change the FY’22 growth profile of the Company.

Overall, the good performance from the medical supplies division (Premma) was offset by the impact of supply chain disruptions on the more volatile sales cycle of the Medical Equipment division (FMS) and investments in human capital to support our ambitious